All of these results suggest that APOBEC3 upregulation in low grade glioma can stimulate macrophages through interferon gamma and activation of myeloid-derived cells, leading to tumor immune response and accelerating tumor cell immune escape by upregulating immune checkpoints. The gene discussed is IFNG; the disease is central nervous system cancer.